"The Role Of Magnetic Resonance Imaging In Prostate Cancer Management" - Dr. Ash Tewari
Magnetic Resonance Imaging (MRI) scans are appropriate for patients age 50 or older, or age 45 if they are at a high risk for prostate cancer by having a family history of prostate or breast cancer or if they are African American. “Then we look at the PSA value and digital rectal exam findings. If any of these are abnormal, that is when we start thinking about MRI,” said Ashutosh Tewari, MBBS, MCh, professor and system chair of urology at the Icahn School of Medicine at Mount Sinai. If MRI reduces the number of biopsies, it also decreases the complications, such as infections and sepsis, associated with biopsy. Dr. Tewari says MRI could be cost effective in the long run, but we don't have the data to show that right now. If MRI can reduce the number of biopsies without missing clinically significant cancers, it will become a viable option.
- Ashutosh Tewari, MBBS, MCh, Professor, System Chair, Urology, Icahn School of Medicine at Mount Sinai
New AI Tool by Mount Sinai Researchers Could Reshape Prostate Cancer Care
Sep 23, 2024 View All Press Releases
Mount Sinai Health System Launches Mobile Prostate Cancer Screening Unit in New York City
Apr 01, 2022 View All Press Releases